Veterinary Medicines

Carporal VET. 40 mg tablets for dogs

Authorised
  • Carprofen
Download as PDF

Product identification

Medicine name:
Carporal VET. 40 mg tablets for dogs
Carporal 40 mg Comprimé
Active substance:
  • Carprofen
Target species:
  • Dog
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Carprofen
    40.00
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Tablet
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QM01AE91
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Luxembourg
Package description:
  • Cardboard box of 50 blisters (Aluminium - PA/ALU/PVC) of 10 tablets
  • Cardboard box of 5 blisters (Aluminium - PA/ALU/PVC) of 10 tablets
  • Cardboard box of 4 blisters (Aluminium - PA/ALU/PVC) of 10 tablets
  • Cardboard box of 25 blisters (Aluminium - PA/ALU/PVC) of 10 tablets
  • Cardboard box of 3 blisters (Aluminium - PA/ALU/PVC) of 10 tablets
  • Cardboard box of 2 blisters (Aluminium - PA/ALU/PVC) of 10 tablets
  • Cardboard box of 10 blisters (Aluminium - PA/ALU/PVC) of 10 tablets
  • Cardboard box of 1 blister (Aluminium - PA/ALU/PVC) of 10 tablets
  • Cardboard box of 6 blisters (Aluminium - PA/ALU/PVC) of 10 tablets
  • Cardboard box of 8 blisters (Aluminium - PA/ALU/PVC) of 10 tablets
  • Cardboard box of 7 blisters (Aluminium - PA/ALU/PVC) of 10 tablets
  • Cardboard box of 9 blisters (Aluminium - PA/ALU/PVC) of 10 tablets

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Hybrid application (Article 13(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Le Vet. Beheer B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Artesan Pharma GmbH & Co. KG
  • Lelypharma B.V.
Responsible authority:
  • Ministere De La Sante Division De La Pharmacie Et Des Medicaments
Authorisation number:
  • V/333/16/01/1495
Date of authorisation status change:
Reference member state:
  • Netherlands
Procedure number:
  • NL/V/0191/001
Concerned member states:
  • Austria
  • Belgium
  • Croatia
  • Cyprus
  • Czechia
  • Denmark
  • Estonia
  • Finland
  • France
  • Greece
  • Hungary
  • Iceland
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Luxembourg
  • Norway
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 15/06/2022
Download